Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical organizations, including the makers of Xarelto, possess a duty to make sure that their drugs are reasonably safe for use - and failure to do so may be grounds for compensation. Our lawyers are operating difficult to get those hurt by the drug the compensation they are entitled to.

While bleeding is really a common complication linked with anticoagulants, it has been alleged that Xarelto is a lot more hazardous than classic blood thinners simply because no antidote exists to reverse its blood-thinning effects. This signifies that, inside the occasion of an emergency, patients might be at danger for irreversible bleeding difficulties, which includes life-threatening internal and gastrointestinal hemorrhaging.

Should you or a loved 1 suffered a serious bleeding occasion following taking Xarelto, you may have legal recourse. For much more info, get in touch with us nowadays to have your case reviewed, free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for previous and future healthcare bills, lost wages, discomfort and suffering and, in situations of death, funeral costs. Additionally, they may be seeking punitive damages, which are typically awarded to punish the defendant and deter other organizations from acting similarly.
Why Are Lawsuits Being Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Since of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding in the event of an emergency. Plaintiffs within the lawsuits allege serious and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and medical staff were not properly made aware of methods how to stop bleeding when on blood thinners stabilize and treat a Xarelto user inside the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.

Visit this page for far more info on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
이 게시물을..